Kashiv BioSciences Names Dr. Sandeep Nilkanth Athalye as Global CEO

Kashiv BioSciences CEO, Dr. Sandeep Nilkanth Athalye ● Photo Credit: 

PISCATAWAY, N.J., November 4, 2024 (VSNewsNetwork.com) - Biopharmaceutical company, Kashiv BioSciences, LLC, has appointed Dr. Sandeep Nilkanth Athalye as Global Chief Executive Officer. Dr. Athalye, who has more than two decades of experience in global pharmaceutical strategy and operations, will oversee Kashiv’s expansion across key markets in the United States, Europe, and Asia. His prior leadership roles include positions with Biocon Biologics, Boehringer Ingelheim, Novartis, and Schering-Plough Research Institute.

Chirag and Chintu Patel, co-founders and board members of Kashiv BioSciences, welcomed Dr. Athalye’s appointment, stating, “We are delighted to welcome Dr. Athalye to Kashiv. His appointment comes at a pivotal time as we accelerate our growth in the rapidly expanding biosimilars sector. We are confident that Dr. Athalye’s industry expertise and leadership will be instrumental in achieving Kashiv’s ambitious global vision.”

“Kashiv is an ambitious biosimilars company founded with a vision to bring affordable and accessible biosimilars globally. Kashiv has a clear objective to be among the top biosimilars players with a differentiated pipeline and state-of-the-art manufacturing and R&D facilities in the U.S. and India. I am very excited for the opportunity to use technology and innovation to drive Kashiv to become one of the leading developers of medicines in the biologics space”, said Athalye.

@VSNewsNetwork

@VSNewsNetwork

Dr. Athalye holds an MBBS in Medicine from Bharati Vidyapeeth, an MS in Clinical Pharmacology from The University of Toledo, and an MBA in BioPharma Innovation from Rutgers University.

For more information on Kashiv BioSciences, visit www.kashivbio.com.

Source: Kashiv BioSciences, LLC